219 related articles for article (PubMed ID: 33658300)
21. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
Kearns B; Whyte S; Seaman HE; Snowball J; Halloran SP; Butler P; Patnick J; Nickerson C; Chilcott J
Br J Cancer; 2016 Feb; 114(3):327-33. PubMed ID: 26766733
[TBL] [Abstract][Full Text] [Related]
22. Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction.
Roslani AC; Abdullah T; Arumugam K
Asian Pac J Cancer Prev; 2012; 13(1):237-41. PubMed ID: 22502676
[TBL] [Abstract][Full Text] [Related]
23. Use of CT colonography in the English Bowel Cancer Screening Programme.
Plumb AA; Halligan S; Nickerson C; Bassett P; Goddard AF; Taylor SA; Patnick J; Burling D
Gut; 2014 Jun; 63(6):964-73. PubMed ID: 23955527
[TBL] [Abstract][Full Text] [Related]
24. Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening.
Carrera A; McClements PL; Watling C; Libby G; Weller D; Brewster DH; Carey FA; Fraser CG; Steele RJ
Colorectal Dis; 2012 Aug; 14(8):943-6. PubMed ID: 21981347
[TBL] [Abstract][Full Text] [Related]
25. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
[TBL] [Abstract][Full Text] [Related]
26. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ
BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941
[TBL] [Abstract][Full Text] [Related]
27. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
28. The impact of stratifying by family history in colorectal cancer screening programs.
Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
[TBL] [Abstract][Full Text] [Related]
29. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
[TBL] [Abstract][Full Text] [Related]
32. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
[TBL] [Abstract][Full Text] [Related]
33. Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma.
Zhang Y; Lu M; Lu B; Liu C; Ma Y; Liu L; Miao X; Qin J; Chen H; Dai M
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00389. PubMed ID: 34408121
[TBL] [Abstract][Full Text] [Related]
34. Reusing a prepaid health plan's fecal immunochemical tests for microbiome associations with colorectal adenoma.
Goedert JJ; Wu Z; Yonehara CH; Frankland TB; Sinha R; Jones GS; Wan Y; Ravel J; Zhao N; Honda SA
Sci Rep; 2022 Aug; 12(1):14801. PubMed ID: 36045142
[TBL] [Abstract][Full Text] [Related]
35. Predictors of repeat participation in the NHS bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
[TBL] [Abstract][Full Text] [Related]
36. Sex differences in performance of fecal occult blood testing.
Brenner H; Haug U; Hundt S
Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
[TBL] [Abstract][Full Text] [Related]
37. Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program.
Koïvogui A; Vincelet C; Abihsera G; Ait-Hadad H; Delattre H; Le Trung T; Bernoux A; Carroll R; Nicolet J
World J Gastroenterol; 2023 Mar; 29(9):1492-1508. PubMed ID: 36998423
[TBL] [Abstract][Full Text] [Related]
38. Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program.
Brezina S; Borkovec M; Baierl A; Bastian F; Futschik A; Gasche N; Gruenberger T; Hallas M; Jannsen C; Leeb G; Lutz R; Sladek B; Gsur A
Gut Microbes; 2023; 15(1):2176119. PubMed ID: 36794815
[TBL] [Abstract][Full Text] [Related]
39. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
40. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
